Cargando…
Consensus Panel, National Guidelines, and Other Potentially Misleading Terms
Autor principal: | Curtiss, Frederic R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437248/ https://www.ncbi.nlm.nih.gov/pubmed/14664671 http://dx.doi.org/10.18553/jmcp.2003.9.6.574 |
Ejemplares similares
-
Who Needs Another Clinical Practice Guideline?
por: Curtiss, Frederic R.
Publicado: (2004) -
Evidence-based Medicine, Practice Guidelines, and Disease Management
por: Curtiss, Frederic R.
Publicado: (2003) -
What Evidence Supports Guidelines for Use of ACE Inhibitors and ARBs in Diabetes?
por: Curtiss, Frederic R.
Publicado: (2006) -
Contractual Arrangements Between HMOs and Medical Groups to Manage Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003) -
Disease Management, Pay-for-Performance, and Clinical Pharmacist Interventions in Diabetes Care
por: Curtiss, Frederic R.
Publicado: (2003)